| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $15.62 (Beat by $6.13) |
| EPS GAAP Actual | $15.62 (Beat by $6.13) |
| Revenue Actual | $3.14799B |
| Revenue Surprise | Beat by $3147.99M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $3.55531 |
| EPS GAAP Estimate | $3.55531 |
| Revenue Estimate | $2.391919707B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 36.66 | 7.26 | 34.00213 | 39.80445 | 0 |
| Dec 2027 | 35.21 | 7.56 | 32.65725 | 38.23008 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 19.47 | 8.69036 | 3.14799B | -19.23% | 119.85M |
| FQ2 2025 (Jun 2025) | 17.25 | 6.39371 | 3.13043B | 9.77% | 48.82M |
| FQ1 2025 (Mar 2025) | 3.29 | 3.29 | 3.47049B | 25.1% | 3470.49M |
| FQ4 2024 (Dec 2024) | -3.84 | -3.84 | 2.27878B | -41.52% | 2278.78M |
| FQ3 2024 (Sep 2024) | 23.03 | 23.03 | 3.75333B | 51.08% | 3753.33M |
| FQ2 2024 (Jun 2024) | 9.61 | 9.61 | 2.82458B | 34.39% | 2824.58M |
| FQ1 2024 (Mar 2024) | 6.96 | 6.96 | 2.59943B | 15.17% | 2599.43M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 3.22489B | 100% | 3224.89M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.55531
Consensus Revenue Estimates
2.391919707B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 10.7588 | -- | 10.29596 | 11.2383 | 2 |
| FQ3 2027 (Sep 2027) | 5.5933 | -- | 5.35268 | 5.84258 | 2 |
| FQ2 2027 (Jun 2027) | 13.9259 | -- | 13.32681 | 14.54655 | 2 |
| FQ1 2027 (Mar 2027) | 13.0205 | -- | 12.46036 | 13.60079 | 2 |
| FQ4 2026 (Oct 2026) | 3.25027 | -- | 2.84505 | 3.63436 | 3 |
| FQ3 2026 (Jul 2026) | 11.66727 | -66.88 | 10.21267 | 13.046 | 4 |
| FQ2 2026 (Jun 2026) | 11.96516 | -44.17 | 11.22258 | 13.31089 | 5 |
| FQ1 2026 (Mar 2026) | 11.47828 | 71.34 | 10.76592 | 12.76925 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 7.82B | -- | 7.57B | 8.09B | 1 |
| FQ3 2027 (Sep 2027) | 7.39B | -- | 7.15B | 7.65B | 1 |
| FQ2 2027 (Jun 2027) | 6.99B | -- | 6.76B | 7.23B | 1 |
| FQ1 2027 (Mar 2027) | 6.6B | -- | 6.39B | 6.83B | 1 |
| FQ4 2026 (Oct 2026) | 2B | -- | 1.81B | 2.18B | 1 |
| FQ3 2026 (Jul 2026) | 3.19B | 1.18 | 2.88B | 3.48B | 1 |
| FQ2 2026 (Jun 2026) | 3.26B | 3.88 | 3.1B | 3.54B | 1 |
| FQ1 2026 (Mar 2026) | 3.43B | -1.13 | 3.27B | 3.73B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 10.77964 | 19.47 | 8.69036 | 44.63% |
| FQ2 2025 (Jun 2025) | 10.85629 | 17.25 | 6.39371 | 37.06% |
| FQ1 2025 (Mar 2025) | 3.29 | 3.29 | 100% | |
| FQ4 2024 (Dec 2024) | -3.84 | -3.84 | 100% | |
| FQ3 2024 (Sep 2024) | 23.03 | 23.03 | 100% | |
| FQ2 2024 (Jun 2024) | 9.61 | 9.61 | 100% | |
| FQ1 2024 (Mar 2024) | 6.96 | 6.96 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.03B | $3.15B | $119.85M | 3.81% |
| FQ2 2025 (Jun 2025) | $3.08B | $3.13B | $48.82M | 1.56% |
| FQ1 2025 (Mar 2025) | $0B | $3.47B | $3470.49M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.28B | $2278.78M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.75B | $3753.33M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.82B | $2824.58M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.6B | $2599.43M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.22B | $3224.89M | 100% |